US 10398706
Heteroaryldiazepine derivatives as RSV inhibitors
granted A61KA61K31/551A61P
Quick answer
US patent 10398706 (Heteroaryldiazepine derivatives as RSV inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/551, A61P, A61P31/14